Thermal Cyclers Market Worth 1.86 Billion 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd.

JERSEY CITY, N.J., June 24, 2024 /PRNewswire/ — InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the Thermal Cyclers Market“- by End-user (Pharmaceutical Industries, Academic and Research Institutes, Diagnostic Laboratories, Others), by Application, Diagnostics, Sequencing Cloning, Genotyping, Mutagenesis, Manufacturing and Quality Control Testing, Clinical Research, Forensics, Others), by Type (Test Mesa Type, Floor Stand Type, Other), by Product Type (Instruments, Accessories, Others), Industry Trends, and Global Forecasts, 2022-2035 And Segment Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global Thermal Cyclers Market is valued at US$ 1.03 Billion in 2023, and it is expected to reach US$ 1.86 Billion by 2031, with a CAGR of 7.8% during the forecast period of 2024-2031.

Thermal Cyclers Market Report Scope: 

Report Attribute

Specifications

Market Size Value In 2023

USD 1.06 Bn

Revenue Forecast In 2031

USD 1.86 Bn

Growth Rate CAGR

CAGR of 7.8% from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Bn and CAGR from 2024 to 2031

Historic Year

2019 to 2022

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Application, By Type, By Product Type, By End-user and By Region

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea

Download Free Sample and ToC of the Report: https://www.insightaceanalytic.com/request-sample/2535 

Thermal cyclers are essential tools in molecular biology research and diagnostics. They work by repeatedly heating and cooling a reaction mixture containing DNA, primers, DNA polymerase, and nucleotides. This cycling process allows the DNA to be replicated millions of times, creating copies of the target segment. PCR is the most common application of thermal cyclers. It is used to amplify DNA for a variety of purposes, such as gene cloning, sequencing, and genetic testing. Thermal cyclers can be used to quantify the expression of genes by measuring the amount of mRNA present in a sample. Thermal cyclers can be used to detect mutations in DNA by identifying changes in the sequence of a gene.

The increasing prevalence of infectious diseases like COVID-19, tuberculosis, and HIV/AIDS has led to a surge in demand for diagnostic tests. Thermal cyclers are crucial tools for PCR-based assays used in diagnosing these diseases. This growth in diagnostics is expected to propel the thermal cycler market. Advancements in thermal cycler technology, such as improved temperature control, faster cycling times, and higher throughput, are making these instruments more efficient and user-friendly.

List of Prominent Players in the Thermal Cyclers Market:

  • Agilent Technologies, Inc
  • Thermo Fisher Scientific Inc
  • Boeckel & Co. GmbH
  • Hamilton Company
  • F. Hoffmann-La Roche Ltd
  • Analytik Jena GmbH
  • Scilogex LLC
  • Biomérieux
  • Bio-Techne
  • GNA Biosolutions GmbH
  • Bio-Rad Laboratories, Inc
  • Eppendorf SE
  • Hercuvan
  • Bioline International
  • DiaSorin S.p.A
  • Others

Order 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2535

Market Dynamics:

Drivers: 

Continuous progress in molecular biology, genomics, and genetic research necessitates the use of thermal cyclers for DNA amplification, making them essential tools in modern laboratories. The rising prevalence of infectious diseases, genetic disorders, and cancer has led to a growing demand for PCR-based diagnostic tests, which rely heavily on thermal cyclers for accurate and rapid results. Additionally, the growth of the biotechnology and pharmaceutical sectors increases the demand for thermal cyclers for applications in drug discovery, genetic engineering, and biopharmaceutical production.

Challenges:

Advanced thermal cyclers with sophisticated features can be expensive, posing a barrier for small laboratories and research institutions with limited budgets. Additionally, operating and maintaining these devices can be technically complex, requiring skilled personnel. This technical complexity can limit the use of thermal cyclers in settings where technical expertise is lacking, further hindering accessibility and widespread adoption in various research and diagnostic environments.

Regional Trends:

The well-established healthcare infrastructure in North America supports extensive use of thermal cyclers in clinical diagnostics, genetic testing, and personalized medicine. Diagnostic laboratories and healthcare facilities in the region rely heavily on PCR-based techniques for disease detection and monitoring. a hub for technological innovation and research in biotechnology, genetics, and molecular biology. North American companies and research institutions often lead in developing and adopting advanced thermal cycler technologies, driving market growth.

Curious About This Latest Version Of The Report? Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/2535 

Recent Developments:

  • In Sept 2023, Bio-Rad Laboratories, Inc., the introduction of its PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers, intended to assist PCR applications in fundamental and translational research, process development, and quality control. The company is a global pioneer in life science research and clinical diagnostic technologies.
  • In Nov 2023, F. Hoffmann-La Roche Ltd,declared the official launch of the LightCycler PRO System . This system is built upon the tried-and-true gold standard technology of the LightCycler Systems that came before it. This novel system bridges the gap between in-vitro diagnostics and translational research, while also raising the standard for performance and usability. Roche’s molecular PCR testing portfolio, which offers solutions for a range of healthcare professionals, including those conducting research and those testing patients for infectious diseases, cancer, and other public health issues, is further enhanced by the LightCycler PRO System.

Segmentation of Thermal Cyclers Market.

By End-user

  • Pharmaceutical Industries
  • Academic and Research Institutes
  • Diagnostic Laboratories
  • Others

By Application

  • Diagnostics
  • Sequencing
  • Cloning
  • Genotyping
  • Mutagenesis
  • Manufacturing and Quality Control Testing
  • Clinical Research
  • Forensics
  • Others

By Type 

  • Test Mesa Type
  • Floor Stand Type
  • Others

By Product Type

  • Instruments
  • Accessories
  • Others

By Region

North America

  • The US
  • Canada
  • Mexico

Europe

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

For More Customization @  https://www.insightaceanalytic.com/customisation/2535 

Why should buy this report:

  • To receive a comprehensive analysis of the prospects for global thermal cyclers market
  • To receive industry overview and future trends of global thermal cyclers market
  • To analyze the thermal cyclers market drivers and challenges
  • To get information on the thermal cyclers market size value (US$ Mn) forecast till 2031
  • Major Investments, Mergers & Acquisition in global thermal cyclers market industry

Other Related Reports Published by InsightAce Analytic:

Digital PCR and Real-Time PCR Market

DNA and Gene Cloning Services Market

Direct-to-Consumer Genetic Testing Market

Check Our Satisfied Clients Portfolio @ https://www.insightaceanalytic.com/our-clients

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact Us:
InsightAce Analytic PVT. LTD
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Follow us on LinkedIn: https://www.linkedin.com/company/insightace-analytic-pvt-ltd/ 

Logo: https://healthtechnologynet.com/wp-content/uploads/2024/06/InsightAce_Analytic_Logo-2.jpg

 

View original content:https://www.prnewswire.com/news-releases/thermal-cyclers-market-worth-1-86-billion-2031–exclusive-report-by-insightace-analytic-pvt-ltd-302180296.html

SOURCE InsightAce Analytic Pvt. Ltd

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

3 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

4 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

4 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

5 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

7 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

7 hours ago